Compare H1B visa sponsorship data between Boehringer Ingelheim Pharmaceuticals and Ernst & Young U.S.. See how they stack up on salary, approval rates, and more.
Key Statistics Comparison
Total H1B Filings
434
Boehringer Ingelheim Pharmaceuticals
+99.2%
53,235
Ernst & Young U.S.
Median Salary
+22.8%
$181,738
Boehringer Ingelheim Pharmaceuticals
$148,000
Ernst & Young U.S.
Approval Rate
100.0%
Boehringer Ingelheim Pharmaceuticals
100.0%
Ernst & Young U.S.
Years Sponsoring
18
Boehringer Ingelheim Pharmaceuticals
18
Ernst & Young U.S.
Historical Trends
H1B Filings Over Time
Boehringer Ingelheim Pharmaceuticals
Ernst & Young U.S.
Median Salary Trend
Boehringer Ingelheim Pharmaceuticals
Ernst & Young U.S.
Where & What They Hire
Top H1B Job Categories
Boehringer Ingelheim Pharmaceuticals
Natural Sciences Managers 4 filings
Bioinformatics Scientists 2 filings
Operations Research Analysts 1 filings
Validation Engineers 1 filings
Biochemists and Biophysicists 1 filings
Ernst & Young U.S.
Accountants and Auditors 580 filings
Database Administrators 449 filings
Software Developers 273 filings
Computer and Information Systems Managers 254 filings
Financial and Investment Analysts 185 filings
Top H1B Work Locations
Boehringer Ingelheim Pharmaceuticals
Ridgefield, CT 11 filings
Danbury, CT 1 filings
Ernst & Young U.S.
New York, NY 275 filings
Chicago, IL 149 filings
San Francisco, CA 98 filings
Hoboken, NJ 97 filings
Dallas, TX 83 filings
Year-by-Year Breakdown
| Year | Boehringer Ingelheim Pharmaceuticals | Ernst & Young U.S. | ||||
|---|---|---|---|---|---|---|
| Filings | Salary | Approval | Filings | Salary | Approval | |
| FY2025 | 12 | $181,738 | 100.0% | 2,264 | $148,000 | 100.0% |
| FY2024 | 1 | $130,000 | 100.0% | 1,379 | $166,114 | 99.6% |
| FY2023 | 8 | $150,000 | 100.0% | 1,447 | $152,685 | 100.0% |
| FY2022 | 8 | $144,941 | 100.0% | 1,856 | $150,000 | 100.0% |
| FY2021 | 7 | $182,306 | 100.0% | 1,244 | $125,000 | 99.9% |
| FY2020 | 6 | $106,375 | 100.0% | 766 | $117,000 | 100.0% |
| FY2019 | 53 | $115,000 | 100.0% | 8,806 | $115,000 | 99.3% |
| FY2018 | 23 | $120,382 | 100.0% | 6,961 | $112,528 | 99.2% |
| FY2017 | 31 | $118,100 | 100.0% | 6,140 | $97,400 | 98.5% |
| FY2016 | 39 | $116,200 | 100.0% | 5,338 | $90,000 | 99.0% |
Showing most recent 10 years of 18 total
Frequently Asked Questions
- Which company pays higher H1B salaries, Boehringer Ingelheim Pharmaceuticals or Ernst & Young U.S.?
- Boehringer Ingelheim Pharmaceuticals pays higher H1B salaries with a median of $181,738 compared to Ernst & Young U.S.'s $148,000.
- Which company sponsors more H1B visas, Boehringer Ingelheim Pharmaceuticals or Ernst & Young U.S.?
- Ernst & Young U.S. has sponsored more H1B visas with 53,235 total filings compared to Boehringer Ingelheim Pharmaceuticals's 434.
- How do Boehringer Ingelheim Pharmaceuticals and Ernst & Young U.S. H1B approval rates compare?
- Boehringer Ingelheim Pharmaceuticals has a 100.0% H1B approval rate while Ernst & Young U.S. has 100.0%. Both companies have the same approval rate.